chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vein throbbing in leg and foot, started continuous for the first two days, initially started in upper leg by knee then mostly moved to foot. And now happens randomly throughout the day 10 times an hour approximately mostly in arm, but also in butt and shoulder and legs. I also feel heart jolts 2-3 times an hour.  Heart rate normal 55-90 when measured this last week. Based on a chat with a friend who is a cardiologist he recommended to stop exercise and caffeine,  and that has been the case for a week now. But currently still experiencing symptoms.
Evening of Tdap and flu shot, I started to experience sharp pain in left shoulder where shots were administered. I had no range of motion in my left shoulder and pain continues to date.
PATIENT STATED THAT HE HAD SEVERE CHILLS/DIZZINESS AND ALMOST FELL DUE TO THIS LAST NIGHT.
Patient states her arm hurt about 5 days. Also she experienced severe lower back discomfort. She could not straighten up. It began the day after the vaccine was given. She has been using her husbands TENS unit which helped, without it she would probably have gone to the hospital. It is beginning to feel better.
Wrong dose (.25ml instead of .5ml) administered for 2nd shot in primary series. Patient brought back to receive remainder of full dose  on 12/3.
Patient received TDAP, Hepatitis A, MENACTRA, and GARDASIL vaccines (in that order).  Three seconds after administration of GARDASIL, patient lost consciousness for approximately 10 seconds.  She had no difficulty breathing after the incident.  I recognize there is a higher rate of vasovagal reactions with GARDASIL.  Patient received no injuries due to her reaction.
This spontaneous report as received from a pharmacist refers to a female patient with unspecified age, with no pertinent medical history or drug reactions / allergies. The pharmacist stated that the patient was vaccinated subcutaneously in the triceps with 0.65 ml dose ZOSTAVAX on 20-AUG-2012. No other co-suspects were reported. Concomitant therapies included "a lot" (therapies unspecified). On 21-AUG-2012 the patient experienced at injection site a knot that was the size of a fist, hot to the touch, redness and heat spreading to the elbow. The reaction was worse at the time of report. The patient would saw the primary care physician in 2 days. At the time of report, the patient had not recovered. The patient call the pharmacist for medical attention. The patient would be put ice on affected area. There were not diagnostic test performed. Additional information has been requested.
Around 10/20 woke up an it was painful to raise arm; pain radiating from left shoulder. Took ADVIL/TYLENOL as needed since doesn't like to take medications. Had annual visit on 1/20/17 and doctor recommended 8 therapy sessions. Physical therapy helped a bit but pain still there. Will go to specialist to get more testing. Pain level at 7-8/10 when raise arm. Pain is mild, notice pain when wake up at night. Today shoulder pain still exist.
Received expired dose of vaccine that had exceeded the 30 day refrigeration limit; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose of vaccine that had exceeded the 30 day refrigeration limit) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose of vaccine that had exceeded the 30 day refrigeration limit). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired dose of vaccine that had exceeded the 30 day refrigeration limit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information was not reported. Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.   Reporter did not allow further contact
Doses administered past the published expiry; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication or treatment information were provided.
Information has been received from a health professional concerning a 34 year old female with no medical history who "as a child" was vaccinated with a second dose of MMR II. There was no concomitant medication. A recent titer showed that she was not immune to mumps. No symptoms were noted. There was no product quality complaint involved. Additional information has been requested.
2nd dose received 2.5 months after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received 2.5 months after the first dose) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 044B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received 2.5 months after the first dose). On 05-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received 2.5 months after the first dose) had resolved.            No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter. The patient denied of experiencing any adverse reactions after 1st or 2nd dose of the vaccine and had already spoken to the physician regarding the effectiveness of the dose.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Follow up received contains updated phone number of reporter and updated narrative
One day post vax, the pt's mom noticed redness and rash on left upper thigh. The following morning she noticed swelling. Left thigh was 1 " larger than right thigh. Pt was seen by a CRNP and was instructed to use ice/cold compresses to right thigh, Benadryl and to monitor the child's temp and behavior. Go to ER with any problems.
Used steroid cream 8 days after getting Moderna 4th booster and senior flu shot. After 2 weeks of using cream I developed severe red, itchy,tingly rash on chest and stomach only on same side of body where used cream and shot booster shot was given in right arm. Could this be related?
Information concerning a 62 year old female who previously underwent a splenectomy was vaccinated with a dose of pneumococcal vaccine 14 polyvalent. The pt developed meningitis and subsequently died. The cause of death was meningitis.
This spontaneous report as received from a registered nurser refers to unspecified number of patients of unknown age and gender. Information about the patient's relevant medical history or concomitant medications was not reported. Since May 2015 (for both vaccines reported as since 08-MAY-2015), the patients were vaccinated with improperly stored doses of GARDASILL (route, dose, lot# and expiration date were not reported). No adverse effect was reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Within a few short minutes of getting vaccination my face perspired profusely and I felt very faint. I had to lay down for 20 minutes before it passed. On the third day after the injection (04/12) I noted a slightly raised red skin coloring at the injection site about 1" X 2". This had not appeared by the morning of 4/10 and was not checked again until 4/12. Throughout the day on 4/12, I had a persistent intermittent tic under my left eye, which I have not had before. It has now subsided.
Headaches; Fatigue; Blood pressure it was 130/83; Heartbeat is 104; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 immunization; Bnt162b2 (Dose 2, single), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "Headaches"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "Fatigue"; HYPERTENSION (non-serious) with onset 2021, outcome "unknown", described as "Blood pressure it was 130/83"; HEART RATE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "Heartbeat is 104". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Medium
Moderna 1/29/21, 2/24/21, 10/17/22. Positive on 1/10/23
ON 4/6 BEGAN TO RUN TEMP OF 102.4 TO 102.5.  WAS GIVEN MOTRIN Q6H.  SEEN IN ER WITH TEMP OF 102.  HAD EPISODES OF STARING, STIFFENING, SHAKING 3 OR 4 TIMES ON SATURDAY. NO VOMITING OR SITE REDNESS. ACCORDING TO MOTHER CHILD WOULD STIFFEN AND MAKE 'HISSING' NOISE FOR SEVERAL MONTHS AFTERWARDS..GRADUALLY QUIT.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE ST ELEVATION MI, RIGHT CORONARY ARTERY
pt recvd vax 2JUN93 & lt index finger very swollen & red from hand to end of fingers; tender to touch referred to MD:
2 days after vaccine administration parents noticed child had red, warm area on left thigh where vaccine had been administered. There was one are that was darker, "like a bruise", per father. There is still lump at site of injection and residual redness lower inner thigh. Area was tender
18 JUN 2007 Recieved Anthrax shot left arm burning pain x 1 week 4/10, 02 July 2007 Anthrax right arm burning pain x 1 week 3/10, Still having nagging soreness remaining after 5 months in bilateral shoulder joints. Never had any problem before no trauma or sports injuries to shoulders. Symptoms are non specific however constant; low burning throbbing irritation in the joint. Full range of motion, no weakness, no radiation of symptoms
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. An 18 year-old female patient of an unspecified race and ethnicity received for immunization the second dose of TRUMENBA (lot M77282, expiry date 29Jun2017) at 0.5 ml single intramuscular in the right deltoid on 31Aug2016 at 3.30 pm. On the same date the patient also received for immunization the third dose of GARDASIL 9 (Merck, lot M016193) and the second dose of INFLUENZA, (Sanofi, lot U55950A), both intramuscular in the left arm. Medical history included anemia since 29Dec2014 for which the patient took iron pills. Concomitant medications were not reported. The patient previously took the first dose of meningococcal group b rlp2086 on unknown date for immunization. On 01Sep2016 the patient experienced symptoms aching/generalized ache, pounding headache, light sensitivities, fever at 103 F, sore throat and heavy feeling in chest. The patient was visited by a physician due to the events but no treatment nor relevant tests were required. She recovered from fever on 03Sep2016, she was recovering from symptoms aching/generalized ache and pounding headache, outcome of the other reported events was unknown. The reporting nurse considered there a reasonable possibility that the events were related to suspect vaccine meningococcal group b rlp2086. Follow-up (23Sep2016): New information reported from the same contactable nurse includes: suspect vaccine details (dose, route, anatomical location and time of administration of meningococcal group b rlp2086, company, route and anatomical location of administration of human papilloma vaccine and influenza vaccine), further details on medical history, reaction data (updated outcome of events symptoms aching, pounding headache, details on physician visit for the events and no treatment/tests required).
Patient needed Tdap which was verbally told to medical assistant. Medical assistant placed order for vaccine approval in computer which was mistakenly signed thinking it was Tdap but it was Td, which was administered to patient. Reporter documented that it would be helpful if the vaccine in computer had the actual component initials (i.e. for HAVRIX it could say HAVRIX (Hep A) instead of just HAVRIX).
On Monday, the same day as the shot... Towards the evening left arm hurting: like someone punched me really hard in the arm (like it did after the first shot) Around 8 PM or so, I started to feel achy and sore, like I had been working outside all day moving heavy items.  My whole body was sore.  Woke up the next morning and felt off.  Took my temp. and it read 101.  I took Tylenol.  Pretty much stayed in bed the whole day.  I was tired and achy.  Fever went up to 103 at around 4 PM.  Took Tylenol.  By the evening I was feeling better.  Next morning I woke up.  Not achy but not 100percent.  Fever at 99, but now I'm dizzy. (This is written on 4-7-21 2:40 pm)
I developed a fever the night after receiving the vaccine, which was expected based on previous COVID vaccine experience. I took my temperature this morning and had a fever of 101.4. I went downstairs and drank a small amount of water. Soon after, my hearing became muffled and I started feeling very lightheaded and sweating. I sat for a bit and then I started having severe lower abdominal pain. I had diarrhea and my hands were getting numb. I went to lay down on the couch and found that both of my hands had frozen in a spasm position and I couldn't move them. My lower legs had the pins and needles feeling but I could still walk. I felt like this for several minutes and eventually told my husband to call EMS. While waiting for the paramedics to arrive, I became nauseous and threw up several times. I still had the bad lower abdominal pain, light-headedness, couldn't move hands, sweating profusely. By the time the paramedics arrived, my symptoms started to subside quickly. I do not know if this was a life-threatening situation but I felt like I might die.  A similar thing happened after my first COVID vaccine (also Pfizer) back in early 2021 except that I didn't lose the ability to use my hands, and the feelings subsided sooner and EMS was not called that time.
Severe dizziness for a day and a half.  Right arm pain, swelling, and redness for 2 days. H/A for one day.
Vaccine administered was stored greater than thirty days in refrigerated temperatures. A case opened with the vaccine manufacturer demonstrated that the vaccines were still safe and effective but requested that we report to VAERS.
PNEUMOVAX 23 was administered to the patient after the excursion occured; No additional Adverse Event reported; This spontaneous report has been received from a registered nurse, concerning to a patient of unknown age and gender.   The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided.  On 18-MAR-2022,  the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot number U022819 which was determined to be valid with expiration date 14-JAN-2023, for prophylaxis, after a temperature excursion of 0 degrees Celsius (C) for a time frame of 24 hours (product storage error) (dose, vaccination scheme, and frequency were not provided). Additionally, a previous temperature excursion was reported.  No additional adverse events (AE) were reported.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2206USA006770: US-009507513-2206USA006587: US-009507513-2206USA007068: US-009507513-2206USA007098:
The patient is not playful, sad.  Staring spells, withdrawn , stiffens lip and rolls his eyes up.  The patient acts like he is in a trance, since he received Prevnar vaccine.
As patient was walking out of the room, she fainted.  Her mother caught her.  She lost consciousness for less than 10 seconds.  She lost control of her bladder.  Clinic personnel provided appropriate comfort and first aid measures: had patient lie down, cold pack, reassurance, monitored for 30 minutes for further adverse responses.
Patient vaccinated x3 (Pfizer): 4/13/21, 5/10/21, 11/15/21  Patient admitted to Medical Center on 1/30/22 after testing positive for COVID19
Mom called clinic today with complaints of rash on left arm. She stated child had fever of 101 at home. Here in clinic at 1:30 PM appointment, are on left arm was red and warm to touch and also firm. Temperature was 99.4 tympanic.
Patient received Quad flu vaccine (by GSK) at 11:00AM 9/20/16 at her place of employment. That night she noticed some swelling at injection site but on Wed morning swelling has spread down her arm to her elbow. Patient stated site was cleansed with alcohol and injection was given 2-3 inches down from top of shoulder. Patient tried ice but had not resolved. Called office 9/22 and instructed OTC ADVIL or TYLENOL and continue ice. MD notified and no further tx needed.
# Sudden Cardiac Death - The afternoon/evening of 11/20. patient was found to be without a pulse  - ACLS performed with intubation, did obtain ROSC   - While prepping to transfer to ICU, patient had recurrent loss pulse and ACLS resume   - Event felt likely related to an arrhythmia due to her severely low ejection fraction   - Family was contacted, requested that CPR be discontinued  Time of Death: 1904
pt recvd TTox vax & 2 days later devel 2-3 cm area of induration, edema, & erythema @ the inject site; 7 days p/inject area had enlarged to five to 6 cm by 10 to 12 cm; reaction persisted for 9 to 10 days & gradually abated;
Pt received anthrax vaccination in L arm 5 April 2008, states red painful swelling started 6 April 2008 at injection site that continued to worsen. Pt went to the MC 9 April 2008 where he received a prescription for Hydroxyzine and Ibuprofen. Pt returned 12 July 08 with completely resolved reaction. Pt not cleared for further Anthrax immunization.
booster; patient believed that it made start period 5 days earlier and it lasted longer than usual; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 01, Batch/lot number: Unknown), for Covid-19 immunization; Bnt162b2 (Dose number: 02, Batch/lot number: Unknown), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 2021, outcome "unknown", described as "booster"; MENSTRUATION IRREGULAR (non-serious) with onset 2021, outcome "unknown", described as "patient believed that it made start period 5 days earlier and it lasted longer than usual".  Additional information: Patient just received booster shot (work in healthcare) and patient believed that it made start period 5 days earlier and it lasted longer than usual. Patient did not use any birth control methods and periods were very regular. Getting the shots and booster are very important and this has not changed patient's mind about it, patient wanted to report it for information as patient know that others have reported this as well. Patient now waiting for 11 YO to receive her vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a adult patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The health care professional reported that the patient experienced soreness and tenderness at the injection site. This was one of the 2 cases reported by same reporter.
History of seizure like activity age 4 days - negative EEG (hosp).  11/8/07 vaccines given (Pediarix) manufacturer GlaxoSmithKline, lot # AC21B128AB, route/site: IM R ant-lat thigh.  1/11/08 admit seizures (24 hrs) - refer neuro.  1/23/08 vaccines given (DT pediarix), manufacturer GlaxoSmithKline, lot # AC21B128AB, route/site: IM R ant-lat thigh.  At development screening 1/23/08 noted mild right-sided fine motor difference.  1/25/08 seizures (T 101.2).  1/27 hospital after 4 seizures which lasted 2 days.  3/11/08 Reviewed hospital medical records for 1/11-1/12/2008  FINAL DX: none provided Records reveal patient experienced recurring seizure activity 2 mos prior, 3 wks prior to admission & seizures x 4 the day of admission accompanied that day w/fever.   Seizure activity lasting approx 1 min included body spasms, rigidity, diaphoresis, eyes rolling back in head, urinary incontinence, apnea followed by hypotonia & unresponsiveness. Parent noted right sided weakness, dragging left leg & sleep disturbance.  Peds neuro consult done.  No seizure activity while hospitalized.  D/C to home w/peds neuro f/u & antiseizure med if recurs for more than 5 min.
Just reporting that I have had irregularities in my menstrual cycle since getting my first shot.  Not sure if it is related to the Pfizer vaccine, but thought I should report since you all are collecting data and monitoring.  Period had started on time the day before I got first shot (Mar 7) and stopped the day of shot (Mar 8).  Then it  came back and had normal duration 17 days later.    Received second shot on Mar 30.  This month, period came on time (28 days since last one) but has lasted longer than normal (currently at 8 days).   I have noticed no other issues since getting shots, other than fatigue and lightheadedness in the days right after.
18OCT97 not using lt arm-notes pain @ site of inj & c/o hand hurts;3NOV97 started using arm p/saw PMD by 2wk was using arm w/o any pain;MD stated it was nl rxn recommended DTAP w/next immun;